Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.
FI: 3,959
Type: Article
Collaboration
Year: 2020
Writers
Minicozzi, P; Vicentini, M; Innos, K; Castro, C; Guevara, M; Stracci, F; Carmona-Garcia, M; Rodriguez-Barranco, M; Vanschoenbeek, K; Rapiti, E; Katalinic, A; Marcos-Gragera, R; VanEycken, L; Sanchez, MJ; Bielska-Lasota, M; Rossi, P.G.; Sant, M.
Magazine
Title: EJSO
Quartile
- Q1